Old National Bancorp Gamida Cell Ltd. Transaction History

Old National Bancorp

  • $4.24 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Feb 17, 2023
BUY
$1.53 - $3.39 $49,083 - $108,754
32,081 New
32,081 $51,000
Q2 2022

Jul 25, 2022
BUY
$1.73 - $4.29 $55,500 - $137,627
32,081 New
32,081 $57,000

Others Institutions Holding GMDA

# of Institutions
2
Shares Held
31.4K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Old National Bancorp Portfolio

Follow Old National Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

News

Stay updated on Old National Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email